Additionally, established tumor markers such as CEA (carcinoembryonic antigen), ESM-1 (endothelial cell-specific molecule-1), and SCC (squamous cell carcinoma antigen) are not fully applicable for clinical diagnosis of OSCC due to their limited sensitivity and specificity (114, 115). This evidence concerns the gene ESM1 and neoplasm.